<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2415">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01549405</url>
  </required_header>
  <id_info>
    <org_study_id>Diskapi</org_study_id>
    <nct_id>NCT01549405</nct_id>
  </id_info>
  <brief_title>Ultrasound-Guided Intercostal Nerve Block for Postoperative Pain Relief in Percutaneous Nephrolitotomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous nephrolitotomy (PCNL)is an endourological procedure for the management of
      patients with renal calculi. Postoperative pain around the surgical area and the nephrostomy
      tube can being a problem. We hypothesized that intercostal nerve block at 11th and 12th rib
      level would alleviate postoperative pain and reduce analgesic consumption.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients admitted for the removal of renal stones by PCNL will included in this
      study.Primary outcome measure will be analgesic (tramadol )consumption and visual analog
      scale (VAS).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Postoperative Analgesic (Tramadol) Consumption</measure>
    <time_frame>Postoperative 24th hour</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Total consumption of tramadol will be measured for the first 24 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Consumption of Tramadol Will be Measured for the First 24 Hours</measure>
    <time_frame>Postoperative 24th hour</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain Will be Evaluated.</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The pain score (VAS)(visual analog scale) will be evaluated for the first 24 hours.(&quot;0&quot; no pain, to &quot;10&quot;, the maximum pain )Pain score less then 4 is acceptable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Nerve Block, Intercostal Nerve</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group: Group that without intercostal nerve block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group that performing intercostal block</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>İntercostal nerve block</intervention_name>
    <description>Nerve block group was administered two levels intercostal block (11 and 12th ribs) with 0.5% bupivacaine with epinephrine before surgery.</description>
    <arm_group_label>nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted for the removal of renal stones by percutaneous

          -  nephrolithotomy (PCNL)

          -  ASA I-II status

        Exclusion Criteria:

          -  Respiratory or cardiac disfunction

          -  Neuropathy

          -  Coagulopathy

          -  BMI (Body mass index)over 30
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derya Özkan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 1. Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Taylan Akkaya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 1. Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emine Arık, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 1. Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zeynep Koç, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 1. Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nihat Karakoyunlu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 3. Urology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haluk Gümüs, MD</last_name>
    <role>Study Chair</role>
    <affiliation>1Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 1. Anesthesiology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hamit Ersoy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 3. Urology Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julide Ergil, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital 1. Anesthesiology Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Derya Özkan</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 1, 2013</lastchanged_date>
  <firstreceived_date>March 7, 2012</firstreceived_date>
  <firstreceived_results_date>February 21, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>derya özkan</investigator_full_name>
    <investigator_title>Consultant of Anesthesiology ,MD</investigator_title>
  </responsible_party>
  <keyword>percutanous nephrolitotomy,intercostal nerve block, Ultrasound</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Control group: Group that without intercostal nerve block</description>
        </group>
        <group group_id="P2">
          <title>Nerve Block</title>
          <description>Group that performing intercostal block
İntercostal nerve block : Nerve block group was administered two levels intercostal block (11 and 12th ribs) with 0.5% bupivacaine with epinephrine before surgery.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>Control group: Group that without intercostal nerve block</description>
        </group>
        <group group_id="B2">
          <title>Nerve Block</title>
          <description>Group that performing intercostal block
İntercostal nerve block : Nerve block group was administered two levels intercostal block (11 and 12th ribs) with 0.5% bupivacaine with epinephrine before surgery.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="20"/>
                <measurement group_id="B3" value="40"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="20"/>
                <measurement group_id="B3" value="40"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57.3" spread="7.4"/>
                <measurement group_id="B2" value="53" spread="13.6"/>
                <measurement group_id="B3" value="55.1" spread="10.2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="7"/>
                <measurement group_id="B3" value="13"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="13"/>
                <measurement group_id="B3" value="27"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Turkey</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="20"/>
                <measurement group_id="B3" value="40"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Analgesic (Tramadol) Consumption</title>
        <description>Total consumption of tramadol will be measured for the first 24 hours.</description>
        <time_frame>Postoperative 24th hour</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain Will be Evaluated.</title>
        <description>The pain score (VAS)(visual analog scale) will be evaluated for the first 24 hours.(“0” no pain, to “10”, the maximum pain )Pain score less then 4 is acceptable.</description>
        <time_frame>24 hours</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Group that without intercostal nerve block</description>
          </group>
          <group group_id="O2">
            <title>İntercostal Nerve Block</title>
            <description>Nerve block group was administered two levels intercostal block (11 and 12th ribs) with 0.5% bupivacaine with epinephrine before surgery.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="20"/>
                  <measurement group_id="O2" value="20"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Postoperative Pain Will be Evaluated.</title>
            <description>The pain score (VAS)(visual analog scale) will be evaluated for the first 24 hours.(“0” no pain, to “10”, the maximum pain )Pain score less then 4 is acceptable.</description>
            <units>units on a scale</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3" lower_limit="2" upper_limit="4"/>
                  <measurement group_id="O2" value="1" lower_limit="0" upper_limit="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.002</p_value>
            <method>Mann-Whitney U test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Consumption of Tramadol Will be Measured for the First 24 Hours</title>
        <time_frame>Postoperative 24th hour</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control group: Group that without intercostal nerve block</description>
          </group>
          <group group_id="O2">
            <title>Nerve Block</title>
            <description>Group that performing intercostal block
İntercostal nerve block : Nerve block group was administered two levels intercostal block (11 and 12th ribs) with 0.5% bupivacaine with epinephrine before surgery.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="20"/>
                  <measurement group_id="O2" value="20"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Total Consumption of Tramadol Will be Measured for the First 24 Hours</title>
            <units>mg</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="199.7" spread="97.5"/>
                  <measurement group_id="O2" value="77.6" spread="39.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.000</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>122.1</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>58</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>52.98</ci_lower_limit>
            <ci_upper_limit>132.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Group that without intercostal nerve block</description>
        </group>
        <group group_id="E2">
          <title>İntercostal Nerve Block</title>
          <description>Nerve block group was administered two levels intercostal block (11 and 12th ribs) with 0.5% bupivacaine with epinephrine before surgery.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Derya Özkan</name_or_title>
      <organization>Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital</organization>
      <phone>00903125962553</phone>
      <email>derya_z@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
